BudMed Bulletin for 25 December 2025
Spread the word about the latest in medical cannabis! Pass on these breakthroughs to empower someone’s health journey.
Want to stay in the loop on game-changing cancer research? Subscribe to us to catch the latest breakthroughs!
CBD and THC Team Up to Selectively Target and Kill Ovarian Cancer Cells!
The CBD + THC combo was strongly effective at killing cancer cells after 48 hours and was much less harmful to healthy cells. The two compounds worked synergistically — meaning together they were more powerful than either one alone or just adding their effects. The mix stopped cancer cells from dividing properly (causing "cell cycle arrest") and triggered more cells to die naturally (apoptosis). Source
Could Cannabidiol Be the Key to Treating Neuropsychiatric Disorders?
CBD's Wide-Ranging Benefits: CBD might help with various brain-related issues because it doesn't just focus on one problem. How It Works: Unlike typical drugs that hit one target, CBD influences many different parts of the body's cells at once. The 'Promiscuous' Nature: CBD's ability to interact with numerous molecular targets means it can adjust multiple body systems simultaneously. Balancing Act: By affecting these various pathways, CBD could help bring balance back to cells or brain circuits that are out of whack. This multitarget approach could explain why CBD has shown potential in: Reducing anxiety (anxiolytic) Preventing or reducing seizures (antiepileptic) Treating symptoms of psychosis (antipsychotic) Helping with addiction (anti-addictive) Source
Medical Cannabis Slashes Depression Severity by Nearly Half in Just 18 Weeks!
Key Results on Effectiveness: Average depression score dropped from 6.9 (moderately severe) at the start to 3.8 (mild) after 18 weeks. This improvement was statistically significant and considered meaningful in real-life terms. About 51% of patients saw their depression symptoms cut by more than half (a common benchmark for "good response" in depression treatments). Source
Struggling with poor sleep? New 12-month study on medical cannabis users in Pennsylvania shows rapid and lasting improvements in self-reported sleep quality
People's self-reported sleep got much better early on and stayed better throughout the whole year. Overall PSQI scores dropped significantly from the start to every follow-up check, with no big changes between the follow-ups. Improvements happened in all areas of sleep measured by the questionnaire. Importantly, sleep improvements were similar no matter how people took the MC (oral vs. other methods) or what their main condition was (chronic pain, anxiety, or PTSD). Source
Unlocking the Body's Own Cannabinoid Secrets for New Treatments!
More importantly, modulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a wide range of disparate diseases and pathological conditions, ranging from mood and anxiety disorders, movement disorders such as Parkinson’s and Huntington’s disease, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome, and osteoporosis, to name just a few. Source
If you received this from a friend and want to subscribe, go here Subscribe to the BudMed Bulletin. You can also follow me on:
Disclaimer: The content provided in this newsletter by BudMed Bulletin is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition or the use of medical cannabis.
